RECRUITING

Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research is to evaluate a novel, integrated approach to providing navigation services to improve cancer outcomes and quality of life.

Official Title

PARTNERS: Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care

Quick Facts

Study Start:2024-07-30

Study Completion:2027-06-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06481774

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* First, investigators will identify individuals who have either had a cancer screening with a suspicious finding (ie. requires diagnostic follow-up) or those individuals who are referred to the UH Seidman Diagnostic Clinic (led by Co-I Hoehn). * Within that group, investigators will recruit those who identify as African American, Hispanic, or living in a prioritized geography as defined by zip code ADI\>=75%ile for state	* Any participant who is not willing or able to complete an informed consent form will not be eligible for this study

Inclusion Criteria

Exclusion Criteria

* First, investigators will identify individuals who have either had a cancer screening with a suspicious finding (ie. requires diagnostic follow-up) or those individuals who are referred to the UH Seidman Diagnostic Clinic (led by Co-I Hoehn).
* Within that group, investigators will recruit those who identify as African American, Hispanic, or living in a prioritized geography as defined by zip code ADI\>=75%ile for state

* Any participant who is not willing or able to complete an informed consent form will not be eligible for this study

Contacts and Locations

Study Contact

Erika Trapl, PhD

CONTACT

216-368-0098

erika.trapl@case.edu

Richard Hoehn

CONTACT

216-844-8904

Richard.Hoehn@uhhospitals.org

Principal Investigator

Erika Trapl, PhD

PRINCIPAL_INVESTIGATOR

Case Western Reserve University, Case Comprehensive Cancer Center

Study Locations (Sites)

Case Comprehensive Cancer Center

Cleveland, Ohio, 44106

United States

Collaborators and Investigators

Sponsor: Case Comprehensive Cancer Center

Erika Trapl, PhD, PRINCIPAL_INVESTIGATOR, Case Western Reserve University, Case Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-30

Study Completion Date2027-06-30

Study Record Updates

Study Start Date2024-07-30

Study Completion Date2027-06-30

Terms related to this study

Keywords Provided by Researchers

Patient navigators

Additional Relevant MeSH Terms

Cancer